SouthState’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
SouthState's MDGL Position: Q3 2026 in Review
SouthState held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 2 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.
SouthState first reported a position in MDGL in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.32K in Q1 2025. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- SouthState held 2 shares of Madrigal Pharmaceuticals worth $1.01K as of Q3 2026.
- SouthState left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1136 holding.
- SouthState first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SouthState's Madrigal Pharmaceuticals position peaked at $1.32K in Q1 2025.
- 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.